Cellgen Diagnostics has recently announced a free whitepaper on a molecular diagnostics platform that can rapidly detect genetic material to identify various illnesses and diseases in humans. It was also said to provide absolute quantification for the purpose of gene expression analysis for research and discovery.
The technology does not require the thermal cycling component, costly enzymes, or sequence specific labeling procedure like PCR/Amplification technologies, and presents as an innovative solution to provide near real time, quantitative results in a number of markets. These include disease diagnosis, veterinary diagnostics, companion diagnostics, food and safety testing, agriculture improvements, environmental testing, GMO testing and biological research testing.
Designed as an open platform able to detect any and all nucleic acid signatures, this detection platform was reported to be able to offer one of the fastest and most sensitive methods available, detecting concentrations as low 10fM. This level of sensitivity was said to enable the detection of nucleic acids in less than 30 minutes.
Will this be the death of qPCR as claimed?